» Articles » PMID: 7565670

A Proline-rich Sequence Unique to MEK1 and MEK2 is Required for Raf Binding and Regulates MEK Function

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 1995 Oct 1
PMID 7565670
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Mammalian MEK1 and MEK2 contain a proline-rich (PR) sequence that is absent both from the yeast homologs Ste7 and Byr1 and from a recently cloned activator of the JNK/stress-activated protein kinases, SEK1/MKK4. Since this PR sequence occurs in MEKs that are regulated by Raf family enzymes but is missing from MEKs and SEKs activated independently of Raf, we sought to investigate the role of this sequence in MEK1 and MEK2 regulation and function. Deletion of the PR sequence from MEK1 blocked the ability of MEK1 to associate with members of the Raf family and markedly attenuated activation of the protein in vivo following growth factor stimulation. In addition, this sequence was necessary for efficient activation of MEK1 in vitro by B-Raf but dispensable for activation by a novel MEK1 activator which we have previously detected in fractionated fibroblast extracts. Furthermore, we found that a phosphorylation site within the PR sequence of MEK1 was required for sustained MEK1 activity in response to serum stimulation of quiescent fibroblasts. Consistent with this observation, we observed that MEK2, which lacks a phosphorylation site at the corresponding position, was activated only transiently following serum stimulation. Finally, we found that deletion of the PR sequence from a constitutively activated MEK1 mutant rendered the protein nontransforming in Rat1 fibroblasts. These observations indicate a critical role for the PR sequence in directing specific protein-protein interactions important for the activation, inactivation, and downstream functioning of the MEKs.

Citing Articles

Exploring the inhibitory potential of xanthohumol on MEK1/2: a molecular docking and dynamics simulation investigation.

Gholizadeh Siahmazgi Z, Irani S, Ghiaseddin A, Soutodeh F, Gohari Z, Afifeh J Res Pharm Sci. 2025; 19(6):669-682.

PMID: 39911899 PMC: 11792713. DOI: 10.4103/RPS.RPS_38_24.


MEK inhibitors in cancer treatment: structural insights, regulation, recent advances and future perspectives.

Ram T, Singh A, Kumar A, Singh H, Pathak P, Grishina M RSC Med Chem. 2023; 14(10):1837-1857.

PMID: 37859720 PMC: 10583825. DOI: 10.1039/d3md00145h.


KLHL7 promotes hepatocellular carcinoma progression and molecular therapy resistance by degrading RASA2.

Chen L, Li Y, Chen Y iScience. 2023; 26(6):106914.

PMID: 37378318 PMC: 10291331. DOI: 10.1016/j.isci.2023.106914.


The mechanism of activation of MEK1 by B-Raf and KSR1.

Maloney R, Zhang M, Liu Y, Jang H, Nussinov R Cell Mol Life Sci. 2022; 79(5):281.

PMID: 35508574 PMC: 9068654. DOI: 10.1007/s00018-022-04296-0.


Ras Isoforms from Lab Benches to Lives-What Are We Missing and How Far Are We?.

Nair A, Kubatzky K, Saha B Int J Mol Sci. 2021; 22(12).

PMID: 34204435 PMC: 8233758. DOI: 10.3390/ijms22126508.


References
1.
Dent P, Chow Y, Wu J, Morrison D, Jove R, Sturgill T . Expression, purification and characterization of recombinant mitogen-activated protein kinase kinases. Biochem J. 1994; 303 ( Pt 1):105-12. PMC: 1137563. DOI: 10.1042/bj3030105. View

2.
Jaiswal R, Moodie S, Wolfman A, Landreth G . The mitogen-activated protein kinase cascade is activated by B-Raf in response to nerve growth factor through interaction with p21ras. Mol Cell Biol. 1994; 14(10):6944-53. PMC: 359225. DOI: 10.1128/mcb.14.10.6944-6953.1994. View

3.
Han J, Lee J, Bibbs L, Ulevitch R . A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science. 1994; 265(5173):808-11. DOI: 10.1126/science.7914033. View

4.
Mansour S, Matten W, Hermann A, Candia J, Rong S, Fukasawa K . Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 1994; 265(5174):966-70. DOI: 10.1126/science.8052857. View

5.
Marshall C . Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell. 1995; 80(2):179-85. DOI: 10.1016/0092-8674(95)90401-8. View